$9.84 Billion is the total value of Paulson & Co.'s 86 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STAY | EXTENDED STAY AMER INCunit 99/99/9999b | $637,791,000 | -8.3% | 42,661,591 | 0.0% | 6.48% | +26.1% | |
| GLD | SPDR GOLD TRUST | $603,896,000 | +7.5% | 4,775,012 | 0.0% | 6.14% | +47.8% | |
| CACQ | CAESARS ACQUISITION COcl a | $147,443,000 | +83.3% | 13,141,098 | 0.0% | 1.50% | +151.9% | |
| CZR | CAESARS ENTMT CORP | $111,051,000 | +13.1% | 14,441,000 | 0.0% | 1.13% | +55.5% | |
| COBALT INTL ENERGY INCnote 3.125% 5/1 | $72,346,000 | -18.0% | 219,229,000 | 0.0% | 0.74% | +12.7% | ||
| AEM | AGNICO EAGLE MINES LTD | $67,442,000 | +47.7% | 1,260,600 | 0.0% | 0.69% | +103.0% | |
| GOLD | RANDGOLD RES LTDadr | $56,020,000 | +23.4% | 500,000 | 0.0% | 0.57% | +69.3% | |
| WLH | LYON WILLIAM HOMEScl a new | $53,561,000 | +11.2% | 3,322,666 | 0.0% | 0.54% | +52.8% | |
| AGN | ALLERGAN PLCcall | $49,615,000 | -13.8% | 214,700 | 0.0% | 0.50% | +18.6% | |
| BACWSA | BANK OF AMERICA CORPORATION* w exp 01/16/2019 | $45,089,000 | -10.5% | 12,956,579 | 0.0% | 0.46% | +22.8% | |
| COBALT INTL ENERGY INCnote 2.625%12/0 | $36,848,000 | -24.8% | 98,260,000 | 0.0% | 0.38% | +3.6% | ||
| ENZY | ENZYMOTEC LTD | $35,314,000 | -7.4% | 4,224,139 | 0.0% | 0.36% | +27.3% | |
| THM | INTERNATIONAL TOWER HILL MIN | $20,291,000 | +185.5% | 23,058,000 | 0.0% | 0.21% | +288.7% | |
| IAG | IAMGOLD CORP | $15,997,000 | +87.3% | 3,863,912 | 0.0% | 0.16% | +158.7% | |
| SYMX | SYNTHESIS ENERGY SYS INC | $10,500,000 | -6.2% | 10,000,000 | 0.0% | 0.11% | +28.9% | |
| KMDA | KAMADA LTD | $2,702,000 | -4.1% | 736,117 | 0.0% | 0.03% | +28.6% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $2,229,000 | +7.2% | 999,700 | 0.0% | 0.02% | +53.3% | |
| INSM | INSMED INC | $2,023,000 | -22.2% | 205,200 | 0.0% | 0.02% | +10.5% | |
| ENDP | ENDO INTL PLCcall | $1,869,000 | -44.6% | 119,900 | 0.0% | 0.02% | -24.0% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $1,008,000 | -41.6% | 102,000 | 0.0% | 0.01% | -23.1% | |
| BCRX | BIOCRYST PHARMACEUTICALS | $747,000 | +0.3% | 263,100 | 0.0% | 0.01% | +33.3% | |
| BACWSB | BANK OF AMERICA CORPORATION* w exp 10/28/2018 | $696,000 | -61.2% | 8,960,537 | 0.0% | 0.01% | -46.2% | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $311,000 | +16.0% | 70,800 | 0.0% | 0.00% | +50.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
| INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
| IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
| ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
| AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
| SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
| ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
| CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
| TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
| Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
| BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
| PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
| Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
| OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
| SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
| Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
| International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
| AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-01-22 |
| SC 13D/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.